KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth

Wenxian Hu1, Yunlu Jia1, Xiangsheng Xiao2

  • 1Department of Surgical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Oncotarget
|May 7, 2016
PubMed

Insights

Krüppel-like factor 4 (KLF4) suppresses lung cancer by inhibiting human telomerase reverse transcriptase (hTERT) and MAPK signaling. This discovery reveals a new therapeutic target for lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Krüppel-like factor 4 (KLF4) has a dual role in cancer, acting as a tumor suppressor or oncogene.
  • The precise mechanism of KLF4's tumor suppressive function in lung cancer requires further elucidation.

Purpose of the Study:

  • To investigate the regulatory mechanism of KLF4 in lung cancer.
  • To determine the relationship between KLF4, hTERT, and the MAPK signaling pathway in lung cancer.

Main Methods:

  • Utilized lung cancer cell lines and a mouse model.
  • Performed promoter reporter assays and chromatin immunoprecipitation (ChIP).
  • Analyzed KLF4 and hTERT expression in patient samples.

Main Results:

  • KLF4 negatively regulated human telomerase reverse transcriptase (hTERT) expression and telomerase activity.
  • KLF4 directly bound to the hTERT promoter region.
  • KLF4 suppressed lung cancer cell proliferation and tumor formation in vivo.
  • The MAPK signaling pathway was implicated in KLF4/hTERT modulation.

Conclusions:

  • KLF4 inhibits lung cancer growth by suppressing hTERT and MAPK signaling.
  • The KLF4/hTERT/MAPK pathway represents a potential therapeutic target for lung cancer.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K